Recently we described the molecular cloning of SLP-76, a hematopoietic cell-specific 76-kD protein that was first identified through its association with GST/Grb2 fusion proteins. The primary sequence of SLP-76 predicts a protein of 533 amino acids comprising an amino-terminal region with numerous potential tyrosine phosphorylation sites, a central region rich in proline residues, and a single carboxy-terminal SH2 domain. Here we demonstrate formally that Grb2 associates with unphosphorylated SLP-76 and map the Grb2 binding site on SLP-76 to amino acids 224-244. We also demonstrate that upon T cell receptor (TCR) stimulation, SLP-76 undergoes rapid tyrosine phosphorylation and associates with tyrosine phosphoproteins of 36, 62, and 130 kD. In vitro experiments show that the SH2 domain of SLP-76 associates with the 62-and 130-kD proteins and additionally with a serine/threonine kinase. Finally, we demonstrate that transient overexpression of SLP-76 results in dramatically enhanced TCR-mediated induction of nuclear factor of activated T cells (NFAT) and interleukin (IL) 2 promoter activity; and we provide evidence that a functional SLP-76 SH2 domain is required for this effect. Our data document the in vivo associations of SLP-76 with several proteins that potentially participate in T cell activation and implicate SLP-76 itself as an important molecule in TCR-mediated IL-2 production. L igation of the TCR results in the rapid activation of several protein tyrosine kinases (PTKs) with the subsequent phosphorylation of numerous cellular proteins (1-3), including components of the TCR itself (2, 3), Src and Syk family PTKs (Lck, Fyn, and ZAP-70 [for review see reference 4]), phospholipase C~/1 (5-7), GAP (8), ezrin (9), CD5 (10, 11), Shc (12), Vav (13, 14) , Cbl (15), and several cytoskeletal proteins (16). However, many substrates of the TCR-activated PTKs remain unidentified. Our laboratory has been interested in characterizing some of these molecules. As one strategy, we chose to investigate tyrosine phosphoproteins that associate with Grb2, an adapter molecule that has been shown to play a central role in coupling fignaling pathways in other systems.
L
igation of the TCR results in the rapid activation of several protein tyrosine kinases (PTKs) with the subsequent phosphorylation of numerous cellular proteins (1) (2) (3) , including components of the TCR itself (2, 3) , Src and Syk family PTKs (Lck, Fyn, and ZAP-70 [for review see reference 4]), phospholipase C~/1 (5-7), GAP (8) , ezrin (9) , CD5 (10, 11) , Shc (12) , Vav (13, 14) , Cbl (15) , and several cytoskeletal proteins (16) . However, many substrates of the TCR-activated PTKs remain unidentified. Our laboratory has been interested in characterizing some of these molecules. As one strategy, we chose to investigate tyrosine phosphoproteins that associate with Grb2, an adapter molecule that has been shown to play a central role in coupling fignaling pathways in other systems.
Using this approach, we and others have demonstrated that tyrosine phosphoproteins of 36, 76, and 116 kD associate with Grb2 in T cells (17) (18) (19) (20) . The 116-kD protein has been identified recently as the product of the c-Cbl protooncogene (15) ; however, its function remains unclear. The molecular identity of the 36-kD protein remains uncertain, but recent data from our laboratory suggest that tyrosine phosphorylation of this molecule is required for coupling the TCK with the phosphatidylinositol second messenger pathway (Motto, D., M. Musci, S. Ross, and G. Koretzky, manuscript submitted for publication). Recently, in a collaborative effort (Paul Findell, Palo Alto, CA), we purified the 76-kD Grb2-associated phosphoprotein and cloned its cDNA, which encodes a novel hematopoietic cell-specific protein we have termed SLP-76, for S_H2 domain leukocyte Erotein of 76 kD (21) . The primary sequence of SLP-76 predicts a protein of 533 amino acids comprising an amino-terminal region with numerous potential tyrosine phosphorylation sites, a central region rich in proline residues, and a single carboxy-terminal SH2 domain. Using glutathione-S-transferase (GST)/SLP-76 fusion proteins and deletion analysis, we now have mapped the Grb2 binding site on SLP-76 to amino acid residues 224-244. Through the use of specific antisera directed against SLP-76, we demonstrate that this molecule becomes rapidly tyrosine phosphorylated after TCR stimulation and associates with several additional tyrosine phosphoproteins. Additionally, in vitro experiments demonstrate that the SH2 domain of SLP-76 associates with a serine/threonine kinase after TCIL ligation. Finally, we demonstrate that transient overexpression of SLP-76 results in dramatically enhanced TCR-mediated induction of the nuclear factor of activated T cells (NFAT) and IL-2 promoter activity. These results implicate SLP-76 as an important molecule in T cell activation.
Materials and Methods
Cell Culture and Antibodies. The humanJurkat T cell line was maintained in RPMI 1640 supplemented with 10% FCS, penicilfin (1,000 U/ml), streptomycin (1,000 U/ml), and glutamine (20 raM). The following antibodies were used in this study: anti-TCR mAb C305 ( [22] ; gift of A. Weiss, University of California, San Francisco, CA); anti-TCR mAb OKT3 (American Type Culture Collection, Rockville, MD); antiphosphotyrosine mAb 4G10 (gift of B. Drucker, University of Oregon, Pordand, OR); anti-Grb2 mAb (Upstate Biotechnology, Inc., Lake Placid, NY); and anti-flag mAb M2 (International Biotechnologies Inc., New Haven, CT). Anti-SLP-76 sheep antiserum 0083 was generated against amino acids 136--235 of human SLP-76 expressed as a GST fusion protein. For immunoprecipitation, the antiserum was conjugated to gamma bind plus Sepharose (Pharmacia, Uppsala, Sweden) and used at ~0.5 ~1/20 • 106 cell equivalents. The antiserum was used at 1:500 for Western blotting.
cDNA Constructs and Fusion Proteins. SLP-76 cDNA was amplified by PCR using reverse-transcribed Jurkat mRNA as a template. This cDNA, which was subcloned into pBluescript (Stratagene Inc., La Jolla, CA) to generate the plasmid pBS/SLP-76/ myc, possesses a COOH-terminal myc epitope tag (EQKLISEEDL) and a silent mutation introducing a Hindlll restriction site at amino acids 229-230. SLP-76 cDNA with an NH2-terminal flag epitope tag (DYKDDDDK) was generated by PCR using pBS/ SLP-76/myc as a template and subcloned into the pEF-BOS mammalian expression vector ( [23] ; gift ofD. Cantrell, Imperial Cancer Research Foundation, London, UK) to generate the plasmid pEF/flag/SLP-76 WT. This SLP-76 cDNA no longer possesses the myc COOH-terminal epitope tag. The flag/SLP-76 DNA encoding a deletion of amino acids 224-244 was generated by PCR using flag/SLP-76 DNA as a template and subcloned into pEF-BOS to generate the plasnfid pEF/flag/SLP-76 A224-244. SLP-76 DNA possessing the R448K mutation was generated by overlap extension PCR using pBS/SLP-76/myc cDNA as a template. This cDNA possesses a silent mutation introducing a KpnI restriction site at amino acids 443-444. The resulting PCR product was subcloned into the plasmid pEF/flag/SLP-76 WT after removal of the corresponding wild-type sequences, resuiting in the plasmid pEF/flag/SLP-76 R448K. The GST/SLP-76 fusion proteins consisting of the indicated amino acids were generated by PCR using reverse-transcribed Jurkat mRNA as a template and subcloned into either the pGEX-2TK or pGEX-3X bacterial expression vectors (Pharmacia). The GST/SLP-76 SH2 domain possessing the loss-of-function R448K mutation was generated by subcloning the overlap extension PCR product described above into the pGEX-3X expression vector. The GST/Grb2, GST/Grb2 SH2, and GST/Grb2 SH2 R86K constructs were generated by PCR and subcloned into pGEX-2TK. GST fusion proteins were induced and affinity purified as described (24) .
Protein Precipitations and Immunoprecipitations. For each experiment, Jurkat cells were left unstimulated or were stimulated with anti-TCR mAb (C305, ascites 1:1,000) for 1 rain unless otherwise noted. Cell lysates prepared in NP-40 lysis buffer (1% NP-40, 150 mM NaC1, 10 mM Tris, pH 7.4) including protease (50 p,g/ ml aprotinin, 10 p~g/rnl leupeptin, 50 ~g/ml pepstatin A, 1 mM PMSF) and phosphatase (400 nM sodium vanadate, 10 mM sodium fluoride, 10 mM sodium pyrophosphate) inhibitors were then subjected to precipitation with the indicated GST fusion proteins or with the indicated antibodies for 2 h at 4~ Resulting protein complexes were then washed extensively in high salt lysis buffer (500 mM NaC1), resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with the indicated mAb or antisera, followed by a horseradish peroxidase-conjugated 2 ~ antibody (Bio-Rad Laboratories, Hercules, CA). Immunoreactive proteins were detected by ECL (Amersham Corp., Arlington Heights, IL).
In Vitro Kinase Assay and Phosphoamino Acid Analysis. Following the standard immunoprecipitation procedure, samples were washed further in 500 mM LiC1, 5 mM Tris, pH 7.4, and once in water. The samples were then resuspended in kinase reaction buffer (10 mM MnC12, 20 mM Tris, pH 7.4) plus [32p]~/ATP (10 ~Ci/sample) for 10 rain at room temperature, washed twice with water, subjected to SDS-8% PAGE, and visualized by autoradiography. The ~100-kD band was excised and subjected to phosphoamino acid analysis as described (25) . Briefly, the sample was rehydrated in 50 mM NH4HCO 3 and extracted twice with 0.1% SDS. The resulting supematants were then precipitated with 20{% TCA, acid hydrolyzed in 50 ~1 of 5.7 M HC1 at 110~ for 10 rain, and dried. The hydrolysate was then resuspended in running buffer (2.5% formic acid, 7.8% acetic acid, pH 1.9) with standards and subjected to TLC with a Hunter Thin Layer Electrophoresis System (CBS Scientific Co., Del Mar, CA). Standards were visualized with 0.25% ninhydrin, and the samples were detected by autoradiography.
Transient Transfections and Luciferase Assays. For transient transfections, log-phase Jurkat cells were electroporated with 40 ~g of the indicated plasmid construct in serum-free RPMI at a density of 107 cells/400 ~1 per cuvette with a gene pulser (Bio-Rad Laboratories) set at 250 V and 960 IxF. For transient transfections before luciferase assays, log-phase ]urkat cells were cotransfected with either 40 ~g of pEF/flag/SLP-76 plasmid or empty vector DNA, plus 20 big of the indicated reporter construct (either NFAT-luc, gift of G. Crabtree, Stanford University, Palo Alto, CA; or plL-21uc2kb, gift of R. Abraham, Mayo Clinic, Rochester, MN), in serum-free RPMI at a density of 107 cells/400 ~xl per cuvette with the conditions specified above. After electroporation, the cells were transferred to complete RPMI and incubated at 37~ for 24 h. Triplicates of 5 • 105 viable cells were then stimulated as indicated for 8 h at 37~ and subsequently assayed for luciferase activity as described (26) . Briefly, cells were lysed in 100 Ixl luciferase lysis buffer (1% Triton X-100, 110 mM K2HPO4, 15 rnM KH2PO4, 5 mM dithiothreitol, pH 7.8) for 10 rain at room temperature. The lysate was then added to 100 txl of 2X luciferase assay buffer (220 mM K2HPO4, 30 mM KH2PO4, 20 mM MgC12, 10 m/vl ATP, pH 7.8), and luciferase activity was quantitated with a luminometer (Monolight 2010; Analytical Luminescence Laboratory, San Diego, CA) immediately after the addition of 100 p,1 of 1 mM luciferin (Sigma Chemical Co., St. Louis, MO).
Results and Discussion
Grb2 Assodates with SLP-76 fiom Resting Cells. Work from our laboratory and others has demonstrated that Grb2 asso- Figure 1 . SLP-76 from resting and TCR-stimulated T cells associates with Grb2. NP-40 lysates of resting or TCR-stimulated Jurkat T cells were precipitated with a full-length GST/Grb2 fusion protein (10 Wg fusion protein, 20 • 106 cell equivalents/condition), and the resulting protein complexes were washed, resolved by SDS-10% PAGE, transferred to nitrocellulose, and immunoblotted with 4G10 antiphosphotyrosine mAb (A), or anti-SLP-76 antisera (B). The migrations of SLP-76, pp36, and pp116 (Cbl) are as indicated. The anti-SLP-76 antiserum was generated against a GST/SLP-76 fusion protein; therefore it also detects the GST/ Grb2 fusion protein in B.
ciates with T lymphocyte tyrosine phosphoproteins of 36, 76, and 116 kD, both in vitro and in vivo ( Fig. 1 A and ref- erences [17] [18] [19] [20] ). Recently we purified the 76-kD protein and isolated its c D N A , which encodes a novel hematopoietic cell-specific protein of 533 amino acids we have named SLP-76 (21) . Specific antisera generated against SLP-76 recognizes a 76-kD protein precipitated by G S T / G r b 2 from lysates of resting and T C R -s t i m u l a t e d Jurkat T cells (Fig. 1  B) , demonstrating formally that the association between Grb2 and SLP-76 is independent of SLP-76 tyrosine phosphorylation.
Mapping of the Grb2-binding Site on SLP-76. Previous work
has demonstrated that the association between Grb2 and SLP-76 is mediated via one or both of the Grb2 SH3 domains (17, 18) . W e therefore reasoned that the SLP-76 Grb2-binding site most likely is located within the prolinerich central domain of SLP-76. To map the Grb2-binding site within SLP-76, we subjected Jurkat cell lysates to precipitation with several G S T / S L P -7 6 fusion proteins encompassing the central proline-rich domain of this molecule (Fig. 2 A) . As shown, the fusion proteins that contain SLP-76 amino acid residues 225-267 precipitate Grb2 (Fig.  2 A, lanes 2-4) , suggesting that the Grb2-binding site is located within the middle third o f the SLP-76 proline-rich domain. In confirmation o f this finding, fusion proteins containing SLP-76 amino acids 225-265 also associate with Grb2 ( Fig. 2 B, lanes 1 and 2) . R e m o v a l o f I> 10 amino acids from the N H 2 terminus o f this sequence completely abrogates Grb2 binding (lanes 3-5), demonstrating that amino acids 225-235 of SLP-76 are required for its association with Grb2. However these amino acids are not suftlcient for Grb2 binding because the fusion protein consisting of SLP-76 amino acids 136-235 does not associate with Grb2 ( Fig. 2 A, lane 1) , suggesting that the amino acids im- mediately following residue 235 also contribute to the Grb2 binding site. In support o f this notion, a synthetic peptide composed o f SLP-76 amino acid residues 229-246 blocks the association between Grb2 and SLP-76 in vitro (not shown). To verify that our experiments with G S T / SLP-76 fusion proteins correctly localized the Grb2-binding site, we constructed and transiently expressed inJurkat cells cDNAs encoding epitope-tagged wild-type SLP-76 and an epitope-tagged SLP-76 mutant possessing a deletion o f amino acids 224-244 (Fig. 2 C) . As shown, although both o f these proteins are expressed similarly, only the wildtype molecule is precipitated by G S T / G r b 2 , demonstrating 
Tyrosine Phosphorylation Time Course and Association of SLP-76 with Several Phosphoproteins after TCR Stimulation.
SLP-76 was identified originally as a Grb2-associated tyrosine phosphoprotein. To demonstrate formally that SLP-76 is a substrate of the TCR-activated PTKs, we subjected anti-SLP-76 immunoprecipitates from lysates o f resting and TCl~.-stimulated Jurkat cells to antiphosphotyrosine Weste m blotting (Fig. 3 A) . As shown, SLP-76 undergoes an increase in tyrosine phosphorylation within 30 s o f TCtL ligation, which peaks by 1 min, and returns nearly to baseline by 60 min o f stimulation. Additionally, when increasing numbers o f Jurkat cells are used, tyrosine phosphoproteins of 36, 62, and 130 kD coimmunoprecipitate with SLP-76 (Fig. 3 B) . The 36-kD protein likely associates with SLP-76 indirectly, via its association with Grb2. pp62 and pp130 interact with the SH2 domain o f SLP-76 as demonstrated by their association with an SLP-76 SH2 domain GST fusion protein (Fig. 3 C) . Mutation o f the predicted phosphate-binding arginine residue o f the SLP-76 SH2 domain to lysine (R448K) completely abrogates binding o f pp62 and pp130, suggesting that the association between these molecules is dependent on tyrosine phosphorylation o f pp62 andpp130 (Fig. 3 C) . Western blotting of GST/SLP-76 SH2 domain precipitations with antibodies against known proteins of similar molecular mass demonstrates that pp62 is not p 6 2 / S A M , and that pp130 is not Cbl, GAP, focal adhesion kinase (FAK), or p130 c^s (not shown). W e are currenfly pursuing the identification o f these molecules.
To characterize further the properties o f proteins that associate with the SLP-76 SH2 domain, we subjected G S T / SLP-76 SH2 domain fusion protein precipitations from resting and TCR-stimulatedJurkat cell lysates to an in vitro kinase assay with [32P]~/ATP (Fig. 4 A) . As shown, T C R stimulation results in increased protein kinase activity detected in the wild-type fusion protein precipitation evidenced by the increased phosphorylation of several protein species as indicated. Interestingly, when the phosphoprotein migrating at 0-~100 kid was excised and subjected to phosphoamino acid analysis, it was found to contain phosphoserine and phosphothreonine, but not phosphotyrosine (Fig.  4 B) . This kinase activity appears to be specific for the SH2 domain o f SLP-76, as the 100-kD phosphoprotein was not detected when a similar experiment was performed using G S T / G r b 2 SH2 domain fusion protein precipitations (Fig.  4 C) . As expected, the wild-type G S T / G r b 2 SH2 domain fusion protein associated with the previously described 36-kD tyrosine phosphoprotein as demonstrated by antiphosphotyrosine Western blotting (not shown): These results suggest that a serine/threonine kinase associates either directly or indirectly with the SH2 domain o f SLP-76 after T C R stimulation. (Fig. 5 A) . As shown, overexpression of SLP-76 greatly augments N F A T activity induced by both T C R ligation and T C R ligation plus phorbol ester stimulation. Western blotting ofceU lysates demonstrated that transient transfection o f SLP-76 results in its overexpression by severalfold (not shown). To determine if SLP-76 overexpression augments transcription from the entire IL-2 promoter, we performed a similar assay using instead a luciferase reporter construct driven by 2 kb of IL-2 promoter sequence (Fig. 5 B) . Similar to what was observed with the N F A T promoter, SLP-76 overexpression enhances IL-2 promoter activity induced by both T C R and T C R plus phorbol ester stimulation. These data suggest that SLP-76 plays a key role in linking the T C R with an important distal event in T cell activation.
Overexpression of SLP-76 Dramatically Enhances TCRmediated N F A T and IL-2 Promoter
W e next investigated whether the associations between SLP-76 and molecules that bind its SH2 domain are required for its function in T C R -m e d i a t e d signaling. As demonstrated above, the R 4 4 8 K mutation abrogates binding of phosphotyrosine-containing proteins to the SLP-76 SH2 domain; therefore we investigated the effect of this loss-of-binding mutation on the ability of SLP-76 to aug-ment TCR-mediated NFAT activity. As shown, overexpression of SLP-76 possessing the R448K mutation is much less effective at enhancing NFAT activity induced by TCR ligation when compared with wild-type SLP-76 (Fig. 5 C) . That this effect is not due to lower level expression of the mutant protein was confirmed by antiepitope Western blotting of cell lysates (Fig 5 D) . These data demonstrate that a functional SH2 domain contributes to the ability of SLP-76 to participate in T cell activation.
SLP-76 was identified originally as a phosphoprotein that associates with Grb2 both in vitro and in vivo (17, 18, 21) . In this report, we map the region of SLP-76 responsible for its association with Grb2 and demonstrate that this interaction is not dependent upon tyrosine phosphorylation. We show further that after TC1L stimulation, SLP-76 becomes rapidly tyrosine phosphorylated and associates in vivo with several unidentified tyrosine phosphoproteins. Two of these proteins, pp62 and pp130, apparently bind the SH2 domain of SLP-76, as evidenced by their association with a GST/ SLP-76 SH2 domain fusion protein. Interestingly, the SLP-76 SH2 domain also appears to bind a serine/threonine kinase after TCR ligation. These findings suggested that SLP-76 plays an important role in linking the TCK with distal events in T cell activation. We tested this hypothesis by assessing the effect ofSLP-76 overexpression on TCR.-mediated induction of NFAT and IL-2 promoter activity and found that these important distal events of T cell activation are indeed dramatically enhanced by SLP-76 overexpression. We demonstrate further that this function of SLP-76 is at least partially dependent on its associations with molecules that bind its SH2 domain, as overexpression of SLP-76 with a nonfunctional SH2 domain is less effective at enhancing TC1L-mediated induction of NFAT activity than is wild-type SLP-76. As these events in wild-type T cells require the coordination of several signaling pathways, including those mediated by PLC~I and Ras (27) (28) (29) , it is not yet clear in which biochemical pathway SLP-76 is functioning. Likewise, it is not yet clear which features of SLP-76 are necessary for its function in these processes. Now that we have identified regions of SLP-76 responsible for its associations with other potential signaling molecules, it will be possible to perform a detailed structure/function analysis of this molecule. Additionally, it will be important to identify tyrosine phosphorylation sites of SLP-76 and determine their contribution to its function. These experiments should help to elucidate further the role of SLP-76 in the process of T cell activation.
